Related Experiment Videos
Hepatitis C virus biology
1Liver Cancer and Molecular Virology, Pasteur-INSERM Unit 370, 156, Rue de Vaugirard 75015 Paris, France.
Insights
Hepatitis C virus (HCV) infection affects millions globally, often leading to severe liver disease. This review explores HCV
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis C virus (HCV) infection is a significant global public health concern, affecting approximately 350 million individuals worldwide.
- Chronic HCV infection frequently progresses to severe liver disease and cancer.
- Current antiviral therapies, primarily interferon (IFN) and ribavirin, achieve sustained viral eradication in less than 50% of treated patients.
Purpose of the Study:
- To review the pathogenetic mechanisms of HCV infection, focusing on viral protein interactions with host cellular signaling pathways.
- To discuss viral strategies for persistence and evasion of antiviral therapy.
- To highlight the challenges in understanding HCV biology due to the lack of reliable in vitro and in vivo models.
Main Methods:
- Review of existing literature and experimental data on HCV pathogenesis.
- Focus on the roles of HCV core, NS3, and NS5A proteins.
- Analysis of host cellular signaling transduction pathways involved in cell growth and viability.
Main Results:
- HCV proteins (core, NS3, NS5A) interact with host signaling pathways regulating cell growth and viability.
- The virus employs specific strategies to persist within the host.
- HCV has developed mechanisms to escape antiviral therapies.
Conclusions:
- Understanding HCV pathogenesis requires further investigation into viral-host interactions.
- Development of improved in vitro and in vivo models is crucial for advancing HCV research.
- Elucidating viral persistence and immune evasion strategies may lead to more effective therapies.
Abstract:
Hepatitis C virus infection represents a major problem of public health with around 350 millions of chronically infected individuals worldwide. The frequent evolution towards severe liver disease and cancer are the main features of HCV chronic infection. Antiviral therapies, mainly based on the combination of IFN and ribavirin can only assure a long term eradication of the virus in less than half of treated patients. The mechanisms underlying HCV pathogenesis and persistence in the host are still largely unknown and the efforts made by researchers in the understanding the viral biology have been hampered by the absence of a reliable in vitro and in vivo system reproducing HCV infection. The present review will mainly focus on viral pathogenetic mechanisms based on the interaction of HCV proteins (especially core, NS3 and NS5A) with host cellular signaling transduction pathways regulating cell growth and viability and on the strategies developed by the virus to persist in the host and escape to antiviral therapy. Past and recent data obtained in this field with different experimental approaches will be discussed.